肺高血圧症を治療するための組成物および方法
In some aspects, the invention teaches pharmaceutical compositions that include a TGF-β ligand trap, and methods of using a TGF-β ligand trap to treat, prevent, or reduce the progression rate of pulmonary hypertension (PH). The invention also provides methods of using a TGF-β ligand trap to treat, p...
Saved in:
| Format | Patent |
|---|---|
| Language | Japanese |
| Published |
20.10.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | In some aspects, the invention teaches pharmaceutical compositions that include a TGF-β ligand trap, and methods of using a TGF-β ligand trap to treat, prevent, or reduce the progression rate of pulmonary hypertension (PH). The invention also provides methods of using a TGF-β ligand trap to treat, prevent, or reduce the progression rate of a variety of conditions including, but not limited to, pulmonary vascular remodeling, pulmonary fibrosis, right ventricular hypertrophy, diseases associated with excessive TGF-β signaling, diseases associated with excessive GDF15 signaling, and diseases associated with excessive PAI-1 signaling. The invention further provides methods of using a TGF-β ligand trap to reduce right ventricular systolic pressure in a subject. |
|---|---|
| AbstractList | In some aspects, the invention teaches pharmaceutical compositions that include a TGF-β ligand trap, and methods of using a TGF-β ligand trap to treat, prevent, or reduce the progression rate of pulmonary hypertension (PH). The invention also provides methods of using a TGF-β ligand trap to treat, prevent, or reduce the progression rate of a variety of conditions including, but not limited to, pulmonary vascular remodeling, pulmonary fibrosis, right ventricular hypertrophy, diseases associated with excessive TGF-β signaling, diseases associated with excessive GDF15 signaling, and diseases associated with excessive PAI-1 signaling. The invention further provides methods of using a TGF-β ligand trap to reduce right ventricular systolic pressure in a subject. |
| BookMark | eNrjYmDJy89L5WSwf9G06-XqGS8WNjyds_z59PbHTZOebdr9fGbT48aZj5u6HzfOf9zU-Lhx3fOtLc86JjzvXPm4setxU8fjxs3Ppu18tnkqDwNrWmJOcSovlOZmUHRzDXH20E0tyI9PLS5ITE7NSy2J9wowszQ1MjQwcHIyMiZGDQDYCEZU |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | JP6952100BB2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_JP6952100BB23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Mar 14 03:32:24 EDT 2025 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Japanese |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_JP6952100BB23 |
| Notes | Application Number: JP20190233811 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211020&DB=EPODOC&CC=JP&NR=6952100B2 |
| ParticipantIDs | epo_espacenet_JP6952100BB2 |
| PublicationCentury | 2000 |
| PublicationDate | 20211020 |
| PublicationDateYYYYMMDD | 2021-10-20 |
| PublicationDate_xml | – month: 10 year: 2021 text: 20211020 day: 20 |
| PublicationDecade | 2020 |
| PublicationYear | 2021 |
| Score | 3.2902195 |
| Snippet | In some aspects, the invention teaches pharmaceutical compositions that include a TGF-β ligand trap, and methods of using a TGF-β ligand trap to treat,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | 肺高血圧症を治療するための組成物および方法 |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211020&DB=EPODOC&locale=&CC=JP&NR=6952100B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTJNBvaTU5N0TYG1ma6JSUqqrkVKajJopjA1LS0lLTklBbxA1s_MI9TEK8I0gokhE7YXBnxOaDn4cERgjkoG5vcScHldgBjEcgGvrSzWT8oECuXbu4XYuqhBe8eg3oyRgZqLk61rgL-Lv7Oas7OtV4CaX5CtmSWwnjIwcAKW1qxGpsZmoNVfrmFOoE0pBcg1ipsgA1sA0LC8EiEGpqxEYQZOZ9jFa8IMHL7Q-W4gE5r1ikUY7F807Xq5esaLhQ1P5yx_Pr39cdOkZ5t2P5_Z9Lhx5uOm7seN8x83NT5uXPd8a8uzjgnPO1c-bux63NTxuHHzs2k7n22eKsqg6OYa4uyhC3RJPNzX8V4BMDc7GRmLMbDk5eelSjAoGJgnW1gaJBulGiYCe1bGaYlGiYZGacnGKakmaUnAuleSQQq3OVL4JKUZuEAhCCqYjQxkGFhKikpTZYE1bkmSHDisAN6Jmkc |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTJNBvaTU5N0TYG1ma6JSUqqrkVKajJopjA1LS0lLTklBbxA1s_MI9TEK8I0golhKWwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o5BvRkjAzUXJ1vXAH8Xf2c1Z2dbrwA1vyBbM0tgPWVg4GQE3fPhnVoJtCql2NbTBZgUVI2M3FxDnD10gY3eeLjF8V4BMG1OoPMNgCU9KzA7GoBWjrmGOYE2tBQg10ZuggxsAUCH5JUIMTBlJQozcDrDLm0TZuDwhc6VA5nQbFsswmD_omnXy9UzXixseDpn-fPp7Y-bJj3btPv5zKbHjTMfN3U_bpz_uKnxceO651tbnnVMeN658nFj1-OmjseNm59N2_ls81RRBkWCDhdjYMnLz0uVYFAwME-2sDRINko1TAT2yozTEo0SDY3Sko1TUk3SkoD1tiSDFG5zpPBJyjNweoT4-sT7ePp5SzNwgWICVMAbGcgwsJQUlabKAmvukiQ5cLgpMOiQEugAjx280A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%E8%82%BA%E9%AB%98%E8%A1%80%E5%9C%A7%E7%97%87%E3%82%92%E6%B2%BB%E7%99%82%E3%81%99%E3%82%8B%E3%81%9F%E3%82%81%E3%81%AE%E7%B5%84%E6%88%90%E7%89%A9%E3%81%8A%E3%82%88%E3%81%B3%E6%96%B9%E6%B3%95&rft.date=2021-10-20&rft.externalDBID=B2&rft.externalDocID=JP6952100BB2 |